Chelsea Therapeutics To Present At The 14th Annual Rodman & Renshaw Global Healthcare Investment Conference

CHARLOTTE, N.C., Sept. 4, 2012 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) is scheduled to present at the 14 th Annual Rodman & Renshaw Global Healthcare Investment Conference at 3:40 PM ET on Monday, September 10, 2012 at the Waldorf Astoria in New York City .

Joseph G. Oliveto, Chelsea's Interim Chief Executive Officer will provide a corporate update and an overview of the Northera™ (droxidopa) development program.

Mr. Oliveto's presentation will be webcast live and archived for 30 days on Chelsea's website, www.chelseatherapeutics.com .

About Chelsea Therapeutics

Chelsea Therapeutics (Nasdaq:CHTP) is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera™ (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure. For more information about the Company, visit www.chelseatherapeutics.com
CONTACT: Investors:         Michelle Carroll/Susan Kim         Argot Partners         212-600-1902         michelle@argotpartners.com         susan@argotpartners.com                  Media:         David Pitts         Argot Partners         212-600-1902         david@argotpartners.com

Chelsea Therapeutics Logo

If you liked this article you might like

Lundbeck to Buy Chelsea Therapeutics for $658M

Why Chelsea Therapeutics (CHTP) Stock Is Soaring Today

Chelsea Exits in Victory With Lundbeck Takeout

Chelsea Therapeutics International Ltd. (CHTP) Shares Soar 14%

'Mad Money' Lightning Round: Zynga Can Go Higher